Profitability Ratios
| Ratio |
Value |
| GP Margin |
81.0% |
| EBIT Margin |
43.6% |
| EBITDA Margin |
50.7% |
| Operating Margin |
41.3% |
| Pretax Margin |
42.2% |
| Cont. Ops Margin |
33.1% |
| Net Margin |
33.1% |
| Bottom Line Margin |
33.1% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
0.80 |
| Quick Ratio |
0.57 |
| Solvency Ratio |
0.357 |
| Cash Ratio |
0.12 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
8.17 |
| Forward PEG |
8.17 |
| Price/Book |
7.42 |
| Price/Sales |
4.66 |
| Price/FCF |
49.64 |
| Price/Op Cash Flow |
12.08 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.2412 |
| Debt/Equity |
0.6749 |
| Debt/Capital |
0.4029 |
| Long-Term Debt/Capital |
0.3626 |
| Financial Leverage |
2.80 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
-6.19 |
| Operating Cash Flow Ratio |
0.552 |
| Operating Cash Flow/Sales |
38.5% |
| Free Cash Flow/Operating Cash Flow |
24.3% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
7.93 |
| Interest Coverage |
30.3442 |
| Short-Term Operating Cash Flow Coverage |
9.91 |
| Operating Cash Flow Coverage |
0.91 |
| Capital Expenditure Coverage |
1.32 |
| Dividend + Capital Expenditure Coverage |
0.84 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
50.5330% |
| Dividend Yield |
3.5969% |
| Dividend Yield % |
3.5969% |
| Dividend Per Share |
11.6378 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
69.49 |
| EPS |
23.030 |
| Debt/Share |
30.3888 |
| Cash/Share |
6.06 |
| Book Value/Share |
43.63 |
| Tangible BV/Share |
14.39 |
| Equity/Share |
43.63 |
| Operating Cash Flow/Share |
26.777 |
| Capital Expenditure/Share |
20.260 |
| FCF/Share |
6.518 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.785 |
| Earnings Before Tax/EBIT |
1.023 |
| Price/Fair Value |
7.42 |
| Debt/Market Cap |
0.0850 |
| Effective Tax Rate |
21.5% |
| Enterprise Value Multiple |
9.85 |
NVO - Novo Nordisk A/S